May 29, 2003

DNA Software Receives Michigan Life Sciences Corridor Award to Commercialize Software for Advanced PCR Assay Design

Ann Arbor, Mich. – May 29, 2003 — DNA Software finalized the terms of its second Michigan Life Sciences Corridor (MLSC) award from the Michigan Economic Development Corporation. $364,000 will be used to commercialize software for microarray and advanced PCR assay design.

DNA Software will use the award to apply the company’s existing software platform, the Oligonucleotide Modeling Platform™ (OMP#153;), to the field of advanced PCR assay design. The new software builds on OMP#153;’s precise modeling engine and will be used by scientists to design microarray experiments.

In 2002, DNA Software received a MLSC Award in the amount of $932,000 to develop software that designs DNA Microarrays.

Donald A. Hicks, the COO of DNA Software expresses his thoughts upon receiving the award. "We are very pleased that the state recognized all of the tremendous progress we have made in the research and development phase during our year one. It's especially gratifying that after an initial investment the state evaluated that our success and progress was more than sufficient to warrant a further investment to help us commercialize these advances."

The thrust of this investment is going to help DNA Software get the word out and reach a wider audience, now that a world leading platform in Visual OMP#153;, the only software platform that integrates simulation and design for nucleic acids for a varity of formats, has been developed.

"With this grant, we will be able to focus on commercialization and developing the business and it should result in increased economic activity and job growth for DNA Software, one of the small, but world leading, companies located here in Ann Arbor" states COO of DNA Software Donald A. Hicks.

Not finding what you’re looking for? Let us help. Click or Call +1.734.222.9080

Our Latest

Thursday, 06 November 2014 22:15

DNA Software introduced the full commercial release of ThermoBLAST Cloud Edition (TB-CE). TB-CE provides a new standard for evaluating the target specificity of oligonucleotides.  Click here to learn more.  

read moreView All News & Events
“We find it [Visual OMP™] makes very accurate and sometimes surprising (but true) predictions about binding efficiency in multiplexes...” David Whitcombe, Chief Scientific Officer, DxS Ltd, UK.
“It [Visual OMP™] is very powerful software when used for multiplexing design...” Chris Novak, Ambion
“I have designed over 10,000 PCR assays in my experience with DNA Software’s Visual OMP™ and found greater than 95% success rate when using it to design my assays compared to less than 20% success without it.” Dr. Eric Bruening, MolecularMD
“I have been using DNA [Software™] for a long time, at least 8 years. I want to have the best tools available and that is why we use it.” Dr. Nancy Schoenbrunner, Roche Molecular Systems
“I am a long-term user of Visual OMP™. I like this program very much because it provides a solid scientific basis for oligo design and cuts the development time by more than half.” Olga Budker, longtime Visual OMP user
“In my experience, DNA Software™ saved me 75% of my oligo costs.” Helen Minnis, Wave 80
“DNA [Software™] has passed my tests. I’ve recommended it [Visual OMP™]. It performs extremely well.” Dr. Ned Sekinger, Luminex Corporation
“Learning to use the program [Visual OMP™] is time well spent, and the support staff at DNA Software is always ready and able to help” Dr. Sue J. Kohlhepp, Providence Portland Medical Center.